This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Frank James King: Innovator in Cytokine Research
Introduction
Frank James King is a notable inventor based in New Milford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the area of cytokine research. His work focuses on the development of therapeutic solutions for autoimmune and inflammatory diseases.
Latest Patents
Frank James King holds a patent for "T cell proteins and nucleotides encoding the same." This invention relates to mouse and human J12 polynucleotides, polypeptides, and anti-J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described in this patent can be utilized in methods for the detection and treatment of certain autoimmune and inflammatory diseases, including asthma. He has 1 patent to his name.
Career Highlights
Frank is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research in the field. His work has the potential to impact the treatment of various health conditions significantly.
Collaborations
Some of his notable coworkers include Jianfei Yang and Jun Li, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Frank James King is a dedicated inventor whose work in cytokine research is paving the way for innovative treatments for autoimmune and inflammatory diseases. His contributions to the field are invaluable and highlight the importance of continued research in biotechnology.